Stocks and Investing Stocks and Investing
Thu, February 8, 2024

Patrick Trucchio Reiterated (ARWR) at Strong Buy and Held Target at $90 on, Feb 8th, 2024


Published on 2024-10-28 08:50:31 - WOPRAI, Patrick Trucchio
  Print publication without navigation


Patrick Trucchio of HC Wainwright & Co., Reiterated "Arrowhead Pharmaceuticals, Inc." (ARWR) at Strong Buy and Held Target at $90 on, Feb 8th, 2024.

Patrick has made no other calls on ARWR in the last 4 months.



There are 4 other peers that have a rating on ARWR. Out of the 4 peers that are also analyzing ARWR, 2 agree with Patrick's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Michael Ulz of "Morgan Stanley" Maintained at Hold with Increased Target to $36 on, Wednesday, February 7th, 2024
  • Shawn Egan of "Citigroup" Maintained at Hold with Increased Target to $34 on, Wednesday, February 7th, 2024


These are the ratings of the 2 analyists that currently disagree with Patrick


  • Luca Issi of "RBC Capital" Reiterated at Buy and Held Target at $50 on, Wednesday, February 7th, 2024
  • Jason Gerberry of "B of A Securities" Maintained at Strong Buy with Increased Target to $37 on, Tuesday, January 2nd, 2024
Contributing Sources